Catalog No.
RHC08502
Species reactivity
Human, Rat, Dog, Guinea pig, Pig, Rabbit
Host species
Rat
Isotype
IgG1, kappa
Clonality
Monoclonal
Target
von Willebrand antigen II, von Willebrand factor, F8VWF, vWF, VWF
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P04275
Applications
Blocking, ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
AJvW-2
Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study., PMID:40508203
Anti-β2GPI/β2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway to increase human neutrophil peptides., PMID:40403008
Perioperative management of transcatheter aortic valve implantation in acquired von Willebrand syndrome secondary to monoclonal gammopathy: a case report., PMID:40395684
Immune Thrombotic Thrombocytopenic Purpura: A Review., PMID:40388146
Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis., PMID:40338657
Topographic relationship between glial cells and neovessels of the epiretinal membrane in proliferative diabetic retinopathy depends on the phase of angiogenesis., PMID:40336843
Polyunsaturated Fatty Acids Improved Long Term Prognosis by Reducing Oxidative Stress, Inflammation, and Endothelial Dysfunction in Acute Coronary Syndromes., PMID:40278275
Optimization of nanobody caplacizumab via computational design., PMID:40226960
A retrospective study on the correlation between antibody levels and endothelial function in SLE patients: An analysis based on ultrasound and serum biomarkers., PMID:40073698
Early administration of caplacizumab combined with plasma exchange for thrombotic microangiopathy due to malignant hypertension: a case report., PMID:40029564
Preventative and therapeutic effects of a novel humanized anti-glycoprotein Ibα fragment of antigen-binding region in a murine model of thrombotic thrombocytopenic purpura., PMID:39956431
Coagulation Profile of Convalescent Plasma Donors and Recipients., PMID:39886886
Efficient and Reproducible Differentiation Protocol for Pluripotent Stem Cells into Functional Endothelial Cells: Unveiling the Path to Vascular Regeneration., PMID:39837100
The epitope of the antibody used in the REAADS VWF activity assay is quaternary., PMID:39825354
By activating endothelium histone H4 mediates oleic acid-induced acute respiratory distress syndrome., PMID:39757148
Jararaca GPIb-binding protein causes thrombocytopenia during Bothrops jararaca envenomation., PMID:39738271
Interpreting high levels of unfolded Von Willebrand Factor in patients with the antiphospholipid syndrome., PMID:39726607
Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis., PMID:39708197
Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura., PMID:39624585
A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic options., PMID:39605214
The role of protein kinase C and the glycoprotein Ibα cytoplasmic tail in anti-glycoprotein Ibα antibody-induced platelet apoptosis and thrombocytopenia., PMID:39541612
Increased thrombin generation in kidney transplant recipients with donor-specific antibodies directed against human leukocyte antigens., PMID:39524447
Current and emerging therapies as potential treatment for people with von Willebrand disease., PMID:39530919
[100 years thrombotic thrombocytopenic purpura (TTP) - lessons learned?]., PMID:39504978
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond., PMID:39467573
Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance., PMID:39446195
Bleeding management in type 3 von Willebrand disease with anti-von Willebrand factor inhibitor: A literature review and case report., PMID:39415910
Refining the standard of care in immune thrombotic thrombocytopenic purpura., PMID:39356816
Risk stratification analysis of recurrent myocardial infarction in Indian population using inflammatory, lipid, thrombotic and extracellular matrix remodeling markers., PMID:39351476
Autoantibodies to ADAMTS13 in human immunodeficiency virus-associated thrombotic thrombocytopenic purpura., PMID:39293938
[Platelet-specific Rictor knockout inhibits platelet production and activation and reduces thrombosis in mice]., PMID:39276057
Improved prevention of bleeding episodes with emicizumab in 3 patients with concomitant hemophilia A and von Willebrand disease., PMID:39248053
Legionella Pneumophila Presenting as a Rare Cause of Acute Thrombocytopenia: A Case Report and Review of Literature., PMID:39247236
Converging pathways: acquired von Willebrand disease in systemic lupus erythematosus with antiphospholipid antibodies presenting with persistent menstrual bleeding., PMID:39231562
A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology., PMID:39228434
A comparative study of anti-ADAMTS-13 antibody dynamics in immune-mediated thrombotic thrombocytopenic purpura., PMID:39221447
The Phenomenon of Thrombotic Microangiopathy in Cancer Patients., PMID:39201740
Platelet-Type von Willebrand Disease: Complex Pathophysiology and Insights on Novel Therapeutic and Diagnostic Strategies., PMID:39191406
Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what's new on the horizon?, PMID:39155445
Animal models for thrombotic thrombocytopenic purpura: a narrative review., PMID:39148951
Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy., PMID:39147240
Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis., PMID:39118148
Percutaneous Left Atrial Appendage Closure in a Patient With Acquired Von Willebrand Disease and Atrial Fibrillation., PMID:39105017
Prevalence and characterization of anti-VWF antibodies in a population of patients with type 3 VWD., PMID:39088757
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma., PMID:38973517
Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience., PMID:38968147
[Advances in the treatment of thrombotic thrombocytopenic purpura]., PMID:38960658
[Novel treatment strategies for acquired hemophilia A]., PMID:38960657
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review., PMID:38936417
Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds., PMID:38761278
For research use only. Not for human or drug use.
